Suppr超能文献

蛋白尿与结直肠癌发病风险的相关性:一项基于全国人群数据库的分析。

Association between proteinuria and incident colorectal cancer: analysis of a nationwide population-based database.

机构信息

The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Department of Cardiology, New Tokyo Hospital, Matsudo, Japan.

出版信息

BMJ Open. 2022 Apr 4;12(4):e056250. doi: 10.1136/bmjopen-2021-056250.

Abstract

OBJECTIVES

This study aimed to assess whether adults with proteinuria were at a higher risk of incident colorectal cancer (CRC) than those without proteinuria using a large-scale population-based database.

DESIGN

A retrospective observational study.

SETTING

The JMDC Claims Database, an administrative health claims database, was used. Data were collected between 2005 and 2020.

PARTICIPANTS

We selected records of participants (n=3 543 705) who underwent health check-ups, including physical examinations, blood tests and urine dipstick tests. We excluded participants who were aged <20 years (n=25 577), had a history of CRC, colorectal disease, renal disease and renal replacement therapy (n=114 888), or had missing data on medications (n=170 145), cigarette smoking (n=14 835), alcohol consumption (n=366 414) or physical activity (n=106 550). Finally, we analysed 2 745 296 participants.

MAIN OUTCOME MEASURES

The primary outcome was CRC at any stage.

RESULTS

Participants were categorised as having no proteinuria (n=2 435 872), trace proteinuria (n=231 153) or positive proteinuria (n=78 271). Over a mean follow-up period of 1189±914 days, 10 615 CRC diagnoses were recorded. The incidence of CRC (95% CI) was lowest in participants without proteinuria (11.7; 95% CI, 11.5 to 11.9 per 10 000 person-years), followed by trace proteinuria (12.5; 95% CI, 11.7 to 13.3 per 10 000 person-years) and positive proteinuria (16.1; 95% CI, 14.6 to 17.7 per 10 000 person-years). After multivariable adjustment, compared with no proteinuria, HRs for incident CRC were 1.20 (95% CI, 1.12 to 1.29) and 1.23 (95% CI, 1.11 to 1.36) for trace and positive proteinuria, respectively. The association between proteinuria and incident CRC existed in participants after multiple imputations for missing data, with a follow-up period of ≥365 days, regardless of age, sex, obesity, hypertension, diabetes mellitus and estimated glomerular filtration rate.

CONCLUSIONS

Trace and positive proteinuria were associated with a greater risk of incident CRC. Assessment of proteinuria could help identify individuals at an increased risk of CRC.

摘要

目的

本研究旨在利用大规模人群数据库评估蛋白尿患者发生结直肠癌(CRC)的风险是否高于无蛋白尿患者。

设计

回顾性观察性研究。

设置

使用 JMDC 理赔数据库,这是一个行政健康理赔数据库。数据收集于 2005 年至 2020 年。

参与者

我们选择了(n=3543705)接受健康检查的参与者记录,包括体检、血液检查和尿液试纸检查。我们排除了年龄<20 岁(n=25577)、有 CRC、结直肠疾病、肾脏疾病和肾脏替代治疗史(n=114888)或药物使用数据缺失(n=170145)、吸烟(n=14835)、饮酒(n=366414)或体力活动(n=106550)的参与者。最后,我们分析了 2745296 名参与者。

主要结局测量

主要结局是任何阶段的 CRC。

结果

参与者被分为无蛋白尿(n=2435872)、微量蛋白尿(n=231153)或阳性蛋白尿(n=78271)。在平均 1189±914 天的随访期间,记录了 10615 例 CRC 诊断。无蛋白尿患者的 CRC 发生率(95%CI)最低(11.7;95%CI,11.5 至 11.9/10000 人年),其次是微量蛋白尿(12.5;95%CI,11.7 至 13.3/10000 人年)和阳性蛋白尿(16.1;95%CI,14.6 至 17.7/10000 人年)。多变量调整后,与无蛋白尿相比,微量蛋白尿和阳性蛋白尿的 CRC 发病风险 HR 分别为 1.20(95%CI,1.12 至 1.29)和 1.23(95%CI,1.11 至 1.36)。蛋白尿与 CRC 发病的关联在缺失数据进行多次插补、随访时间≥365 天的参与者中仍然存在,且与年龄、性别、肥胖、高血压、糖尿病和估计肾小球滤过率无关。

结论

微量蛋白尿和阳性蛋白尿与 CRC 发病风险增加相关。评估蛋白尿可能有助于识别 CRC 风险增加的个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/8981279/e9620f273499/bmjopen-2021-056250f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验